Business Summary
AsiDNA® is the first compound derived from platON®, a first-in-class inhibitor developed by the company. Based on a novel decoy and agonist mechanism acting upstream of multiple DDR pathways, it is highly differentiated from the tumor DNA damage response. Valerio Therapeutics is also developing OX425, a novel platON®-generated drug candidate optimized to be a next-generation PARP inhibitor, acting on both the DNA damage response and the activation of the immune response, without inducing resistance. OX425 is currently undergoing Investigational New Drug (IND)-enabling preclinical development.
Number of employees: 19
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology Products
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +24.74% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rest of the World
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +24.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shefali Agarwal
CEO | Chief Executive Officer | 50 | 31/05/21 |
Julien Miara
BRD | Director/Board Member | 41 | 16/09/20 |
Valérie Leroy
IRC | Investor Relations Contact | - | 30/11/16 |
Hui Ping Jiang
LAW | General Counsel | - | - |
Philippe Maitre
PRN | Corporate Officer/Principal | 68 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Mallet
BRD | Director/Board Member | 64 | 13/10/21 |
Khalil Barrage
BRD | Director/Board Member | 59 | - |
Director/Board Member | 61 | 28/06/11 | |
Julien Miara
BRD | Director/Board Member | 41 | 16/09/20 |
Bryan Giraudo
BRD | Director/Board Member | 49 | 22/11/21 |
Shefali Agarwal
CEO | Chief Executive Officer | 50 | 31/05/21 |
Robert Coleman
BRD | Director/Board Member | 62 | 13/10/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 154,364,273 | 106,900,017 ( 69.25 %) | 368,174 ( 0.2385 %) | 69.25 % |
Company contact information
Valerio Therapeutics SA
49, blvd. du Général Martial Valin
75015, Paris
+33 1 70 38 33 99
http://www.valeriotx.comSector
1st Jan change | Capi. | |
---|---|---|
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 314B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B |